Colorectal cancer: morphologic variables related with carcinoembryonic antigen serum elevation (CEA). 1998

L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
Department of Surgery, General Hospital, Soria, Spain.

OBJECTIVE The purpose of this study is to identify morphologic parameters of colorectal adenocarcinoma which may be of influence in the increase of preoperatory CEA serum levels. METHODS This study includes 127 patients on whom colectomy was performed. Twenty-eight morphologic parameters were analyzed in each surgical specimen. Serum determinations were made by enzymatic immunoassay. A multivariate study (logistic regression analysis) was made. Independent risk factors for CEA serum elevation were Cytologic Atypia (odd ratio: 2.85) Infiltrative Growth Pattern (odd ratio: 2.91) and the presence of tumoral cell infiltration directly among adipocytes (odd ratio: 2.62). When clinical variables (age, sex, tumor location, perforation, occlusion, hepatic metastases and peritoneal carcinomatosis) were added the infiltrative growth pattern (odd ratio: 3.12) and cytologic atypia persisted as independent risk factors, together with the clinical variable Hepatic Metastases (odd ratio: 24.84). CONCLUSIONS In our series the morphologic variables Infiltrative Growth Pattern and Cytologic Atypia are independently related with CEA serum increase and are not influenced by the variable Hepatic Metastases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
December 1976, Annals of surgery,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
January 2011, Hepato-gastroenterology,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
August 2001, Revista espanola de medicina nuclear,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
August 1975, Comprehensive therapy,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
August 1986, Ginekologia polska,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
October 1976, AJR. American journal of roentgenology,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
September 1991, Annals of Saudi medicine,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
August 2014, Cancer science,
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
January 1985, Polski tygodnik lekarski (Warsaw, Poland : 1960),
L Fernández Fernández, and J Alfaro, and C Hijar, and E Tejero, and M Pilar Sanz
January 1976, Immunochemistry,
Copied contents to your clipboard!